ARYTX
Price
$13.20
Change
+$0.04 (+0.30%)
Updated
Jul 3 closing price
Net Assets
855.62M
MGLJX
Price
$16.46
Change
+$0.01 (+0.06%)
Updated
Jul 3 closing price
Net Assets
2.31B
Interact to see
Advertisement

ARYTX vs MGLJX

Header iconARYTX vs MGLJX Comparison
Open Charts ARYTX vs MGLJXBanner chart's image
American Century Global Real Estate C
Price$13.20
Change+$0.04 (+0.30%)
VolumeN/A
Net Assets855.62M
MFS Global Real Estate R1
Price$16.46
Change+$0.01 (+0.06%)
VolumeN/A
Net Assets2.31B
ARYTX vs MGLJX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARYTX vs. MGLJX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARYTX is a Buy and MGLJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLJX has more cash in the bank: 2.31B vs. ARYTX (856M). MGLJX pays higher dividends than ARYTX: MGLJX (1.53) vs ARYTX (1.07). ARYTX was incepted earlier than MGLJX: ARYTX (14 years) vs MGLJX (11 years). ARYTX (2.12) is less costly to investors than MGLJX (1.95). ARYTX is a more actively managed with annual turnover of: 130.00 vs. MGLJX (48.00). MGLJX has a lower initial minimum investment than ARYTX: MGLJX (0) vs ARYTX (2500). ARYTX annual gain was more profitable for investors over the last year : 8.37 vs. MGLJX (4.49). ARYTX return over 5 years is better than : 22.20 vs. MGLJX (9.26).
ARYTXMGLJXARYTX / MGLJX
Total Expense Ratio2.121.94109%
Annual Report Gross Expense Ratio2.121.95109%
Fund Existence14 years11 years-
Gain YTD2.8843.45783%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets856M2.31B37%
Annual Yield % from dividends1.071.5370%
Returns for 1 year8.374.49187%
Returns for 3 years12.58-4.12-306%
Returns for 5 years22.209.26240%
Returns for 10 years39.3413.89283%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVKD12.980.54
+4.34%
Cadrenal Therapeutics Inc
PLTR134.362.24
+1.70%
Palantir Technologies
CRVL102.851.46
+1.44%
CorVel Corp
VERV11.280.07
+0.62%
Verve Therapeutics
BARK0.91-0.03
-2.70%
BARK